<SEC-DOCUMENT>0001493152-21-018514-index.html : 20210804
<SEC-HEADER>0001493152-21-018514.hdr.sgml : 20210804
<ACCEPTANCE-DATETIME>20210804094322
ACCESSION NUMBER:		0001493152-21-018514
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210804
DATE AS OF CHANGE:		20210804

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BriaCell Therapeutics Corp.
		CENTRAL INDEX KEY:			0001610820
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92289
		FILM NUMBER:		211142617

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1
		BUSINESS PHONE:		(604) 921-1810

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ansell Capital Corp.
		DATE OF NAME CHANGE:	20140613

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			L5 Capital Inc.
		CENTRAL INDEX KEY:			0001869759
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		STREET 2:		39TH FLOOR
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1H3
		BUSINESS PHONE:		5142437438

	MAIL ADDRESS:	
		STREET 1:		1 FIRST CANADIAN PLACE
		STREET 2:		39TH FLOOR
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1H3
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>sc13ga.htm
<TEXT>
Document 1 - file: sc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>